Table 1.

Participant characteristics

CharacteristicType 2 DiabetesHealthy ControlsP Value
Weight, kg99.6 ± 17.071.2 ± 13.6<0.001
Height, cm169.4 ± 11.8168.8 ± 7.40.89
BMI34.8 ± 5.924.8 ± 3.6<0.001
Age, yr57.9 ± 5.455.8 ± 9.00.53
o2peak, ml·kg−1·min−118.9 ± 4.031.4 ± 4.5<0.001
Wattpeak, W147.6 ± 34.0189.4 ± 43.10.03
Metformin only (n)70NA
Sulfonylurea + GLP1 agonist10NA
SGLT2 inhibitor + GLP1 agonist10NA
DPP4 inhibitor10NA

Data are expressed as means ± SD. Type 2 diabetes: n = 5 males, n = 5 females. Healthy controls: n = 4 males, n = 5 females. BMI, body mass index; GLP1, glucagon-like peptide; SGLT2, sodium-dependent glucose transporter-2; NA, not applicable.